Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 438 out of 492
4918 citations found

New 9-aminoacridine derivatives as inhibitors of botulinum neurotoxins and P. falciparum malaria

TOT, M;OPSENICA, DM;MITRIC, M;BURNETT, JC;GOMBA, L;BAVARI, S;OLAJA, BA;

Product: Botulinum Neurotoxin Type B Light Chain, Recombinant

  • In vitro BoNT LC metalloprotease activity:

    Determination of BoNT/A LC percent inhibition by SMNPIs was performed as previously described.  For BoNT/B LC percent inhibition, the HTS-assay utilizes a commercially available fluorogenic substrate from List Biological Laboratories (Campbell, CA). Briefly, a multichannel pipette was used to add fluorescent substrate (final concentration 20 M) and small molecules (final concentration 20 M) to a 96 well microplate. The reactions were initiated by adding recombinant BoNT/B LC (final concentration 40 nM) to each well. All reactions were conducted in a buffered solution consisting of 40 mM Hepes pH 7.2, 1 mM DTT and 100 M ZnCl2. The change in fluorescence intensity over time was continuously monitored in each well using a 96 well plate fluorimeter (Saphire 2, Tecan, Mnnedorf, Switzerland). The assays were run at 37 C, quenched by the addition of TFA, and analyzed using reverse-phase HPLC. Potential SMNPIs of the BoNT B LC were identified by comparing the reaction velocities (change in fluorescence intensity over time) of samples assayed in the presence of compounds versus  control samples.

    Author did not specify which List Biological Laboratories product was utilized.  Refer to the follwing List Labs link for Botulinum products available:  https://listlabs.com/product-information/botulinum-toxins/

Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response

Ehrentraut, SF;Kominsky, DJ;Glover, LE;Campbell, EL;Kelly, CJ;Bowers, BE;Bayless, AJ;Colgan, SP;

Product: LPS from Escherichia coli O55:B5

  • Cell treatments:

    For Western blot experiments and luciferase assays the following treatment regimen was used. Six hours prior to harvesting, cells were treated with 10 mg/ml medium of Escherichia coliderived LPS (E. coli 055:B5; List Biological Laboratories, Campbell, CA), …

    NOTE:  At the time this paper was written, Product #203 (5mg – LPS from Escherichia coli O55:B5) was utilized.

    Product #203 (5 mg – LPS from Escherichia coli O55:B5) is no longer sold.

    Product #203A (2.5 mg – LPS from Escherichia coli O55:B5) is available for purchase.

MicroCor Transdermal Delivery System: A Safe, Efficient, and Convenient Transdermal System for Vaccine Administration

Singh, P;Chen, G;Worsham, W;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimen

Zhang, J;Jex, E;Feng, T;Sivko, GS;Baillie, LW;Goldman, S;Van Kampen, KR;Tang, DC;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B

Jin, K;Wang, S;Zhang, C;Xiao, Y;Lu, S;Huang, Z;

Product: Toxin A from Clostridium difficile

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Administration of BCG and CT:

    The M. bovis BCG Tokyo 172 strain (Japan BCG Laboratory, Tokyo, Japan) was prepared as… CT and CTB were purchased from List Biological Lab, Campbell, CA. Groups of mice (6 mice/group) were given 50 µl of saline containing 500 µg of BCG and 1 µg of CT, 500 µg of BCG, 1µg of CT, or saline (controls) intranasally at 0 h, and samples were collected at 24 h. The intranasal doses of BCG and CT were based on previous studies…

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

The regulation of epithelial cell proliferation and growth by IL-1 receptor antagonist

Kondo, M;Yamato, M;Takagi, R;Namiki, H;Okano, T;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Blockade of peanut allergy with a novel Ara h 2-Fc fusion protein in mice

Liu, Y;Sun, Y;Chang, LJ;Li, N;Li, H;Yu, Y;Bryce, PJ;Grammer, LC;Schleimer, RP;Zhu, D;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization

Chu, DK;Llop-Guevara, A;Walker, TD;Flader, K;Goncharova, S;Boudreau, JE;Moore, CL;Seunghyun In, T;Waserman, S;Coyle, AJ;Kolbeck, R;Humbles, AA;Jordana, M;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae